ScholarIQanswers from OpenAlex

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris

PaperCitations, authors & open-access status

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris have?

ScholarIQcitation count

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris has 62 citations in the OpenAlex counts ScholarIQ stores.

When was Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris published?

ScholarIQyear

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris has 2014 year in the ScholarIQ index.

What is the open-access status of Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris?

ScholarIQoa status

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris has closed oa status in the ScholarIQ index.

What is the DOI of Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris?

ScholarIQdoi

The DOI for Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris is on the source record.

What is the PMID of Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris?

ScholarIQpmid

The PMID for Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris is on the source record.

What is the OpenAlex record for Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris?

ScholarIQopenalex

The OpenAlex for Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial